ZIPUZEP
Live / Registered — Registered (as of 16 Nov 2021)
What this means for you
Registered since 16 Nov 2021. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Nov 2027: the §71 affidavit of use).
Record
- Serial number
- 79305231
- Registration number
- 6557578
- Mark type
- Word mark
- Filed
- 22 Dec 2020
- Published for opposition
- 27 Jul 2021
- Registered
- 16 Nov 2021
- Next maintenance filing
- §71 affidavit of use, due by 16 Nov 2027 (grace period to 16 May 2028)
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products, namely, pharmaceutical preparations for allergy treatment
- Class 010 — Medical apparatus: Medical apparatus and instruments, namely, needleless injectors comprising a subcutaneous and/or intramuscular intradermal injection system; syringes for medical use
Owner
Board proceedings on this mark
- Extension of Time to Oppose No. 79305231 — APRECIA PHARMACEUTICALS, LLC v. CROSSJECT, filed 26 Aug 2021 (Terminated)
Prosecution history
- 26 Mar 2022 — NOTIFICATION PROCESSED BY IB
- 05 Mar 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 05 Mar 2022 — FINAL DISPOSITION PROCESSED
- 16 Dec 2021 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 16 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
- 06 Oct 2021 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 26 Aug 2021 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 27 Jul 2021 — PUBLISHED FOR OPPOSITION
- 07 Jul 2021 — NOTICE OF PUBLICATION
- 19 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2021 — ASSIGNED TO EXAMINER
- 09 Mar 2021 — APPLICATION FILING RECEIPT MAILED
- 05 Mar 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 04 Mar 2021 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 25 Feb 2021 — SN ASSIGNED FOR SECT 66A APPL FROM IB